BIO-TECHNE Corp (TECH) stock

TECHNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends June 30

Financials through Q1 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 11/3040% above fair value

$72.80−0.02 (-0.03%)

Close on Nov 11, 2026Market cap $11.43BP/E 66.8Yield 0.44%

Bio-Techne EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

Bio-Techne's EV/EBITDA was 32.3× on Nov 2, 2026, against 47.2× a year earlier. Over the last 5 years it ranged from 21.6× to 59.5×, with a median of 33.4×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2026	Nov 2, 2026	32.3×	−10.8
2025	Dec 31, 2025	43.1×	+4.9
2024	Dec 31, 2024	38.3×	+7.6
2023	Dec 29, 2023	30.7×	−2.6
2022	Dec 30, 2022	33.3×	−26.2
2021	Dec 31, 2021	59.5×	+11.2
2020	Dec 31, 2020	48.3×	+10.9
2019	Dec 31, 2019	37.5×	+8.4
2018	Dec 31, 2018	29.1×	+0.6
2017	Dec 29, 2017	28.5×	+7.4
2016	Dec 30, 2016	21.1×	+2.1
2015	Dec 31, 2015	19.0×	−0.2
2014	Dec 31, 2014	19.2×	−207.0
2013	Dec 31, 2013	226.2×	+212.6
2012	Dec 31, 2012	13.6×	−0.0
2011	Dec 30, 2011	13.6×	−0.2
2010	Dec 31, 2010	13.8×	−1.6
2009	Dec 31, 2009	15.4×	–